A Multi-center, Randomized, Double-blind, Parallel-group Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R212 Fixed Dose Combination in Patients With Dyslipidemia and Hypertension
Latest Information Update: 08 Jun 2017
At a glance
- Drugs Amlodipine/rosuvastatin (Primary)
- Indications Hypercholesterolaemia; Hypertension
- Focus Therapeutic Use
- Sponsors Alvogen Korea
- 01 Jun 2017 Status changed from not yet recruiting to withdrawn prior to enrolment as the study was canceled.
- 10 Nov 2016 New trial record